SciELO - Scientific Electronic Library Online

 
vol.38 número133Un enfoque alternativo del tratamiento farmacológico en psiquiatríaAcerca del influyente estudio STAR*D sobre la clínica con antidepresivos: sesgos y resultados índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista de la Asociación Española de Neuropsiquiatría

versão On-line ISSN 2340-2733versão impressa ISSN 0211-5735

Resumo

HEALY, David; LE NOURY, Joanna  e  JUREIDINI, Jon. Antidepressants in pediatrics: the greatest failing in health care?. Rev. Asoc. Esp. Neuropsiq. [online]. 2018, vol.38, n.133, pp.195-216. ISSN 2340-2733.  https://dx.doi.org/10.4321/s0211-57352018000100011.

Children's mental health services are said to be the biggest failure in Britain's National Health Service, specially, with regard to the treatment of depression and suicidal behaviour in children and adolescents. The use of antidepressants in children and adolescents shows the largest gap existing in health services between clinical practice and scientific evidence, among open label studies that claim its benefits and a big number of randomized controlled trials (RCTs) that indicate the opposite, and among RCTs as they are published and advertised and what their data actually prove. However, antidepressants are commonly used and they probably are the most prescribed drugs in adolescents. The context of antidepressant use during childhood, the evidence analysis, the harms and risks, the increase of suicidal events, and other issues related to clinical practice are addressed. The place of SSRIs in clinical practice might be related to their potential serenic effect, different from the anxiolytic effect of benzodiazepines and antipsychotics. If “this therapeutic principle” were considered as primary outcome, it would allow a better understanding of RCT data and a clinical practice based on a more balanced risk-benefit ratio. Its application would require a collaborative work with patients and a significant degree of autonomy with regards to what is included in the clinical guidelines. The paper examines general troubles of healthcare services, their sustainability, health promotion, and drug use, comparing the diagnosis and treatment of child and youth depression with those of osteoporosis and other diseases, like asthma and high blood pressure. Finally, a free access campaign to clinical trial data is advocated.

Palavras-chave : depression; suicidal behaviour; children and adolescents; antidepressants; SSRIs.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )